← Back to Search

Behavioural Intervention

CBIT group for Chronic Tic Disorder

N/A
Recruiting
Led By Christine Conelea, PhD, LP
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 10-17 years at time of enrollment
Current chronic motor and/or vocal tics, defined as tics for at least 1 year without a tic-free period of more than 3 consecutive months. Tics must not be due to a medical condition or the direct physiological effects of a substance
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 27 weeks
Awards & highlights

Study Summary

This trial is studying Tourette Syndrome and Persistent Motor/Vocal Tic Disorder in young people. These conditions can cause problems with functioning, emotions, and behavior. The main symptom is chronic tics. The

Who is the study for?
This trial is for young people with tic disorders, including Tourette Syndrome and Chronic Tic Disorder. Participants should be experiencing chronic tics that impact their daily life. The study aims to help them manage their symptoms through a treatment called CBIT.Check my eligibility
What is being tested?
The trial tests Comprehensive Behavioral Intervention for Tics (CBIT), which teaches patients how to control tics using competing motor actions. It involves an 8-session course where the effectiveness of CBIT will be evaluated through various assessments and video recordings.See study design
What are the potential side effects?
Since CBIT is a behavioral intervention rather than a medication, it does not have typical drug side effects. However, participants may experience fatigue or frustration during the learning process of new techniques to manage their tics.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 10 and 17 years old.
Select...
I have had motor or vocal tics for over a year without a break longer than 3 months.
Select...
My tics are at least moderate in severity.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~27 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 27 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in the Total Tic Score on the Yale Global Tic Severity Scale (YGTSS).
Secondary outcome measures
Change resting-state fMRI connectivity of the brain
Components of CBIT sessions
Identify CBIT process elements that contribute to response
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: CBIT groupExperimental Treatment1 Intervention
Participants with chronic TICs

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,381 Previous Clinical Trials
1,588,875 Total Patients Enrolled
Christine Conelea, PhD, LPPrincipal InvestigatorUniversity of Minnesota
Deanna Greene, PhDPrincipal InvestigatorUniversity of California, San Diego

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the specific criteria that individuals must meet in order to be eligible for participation in this trial?

"To be eligible for this research study, potential participants must have a confirmed diagnosis of Tourette syndrome and fall within the age range of 10 to 17 years old. The trial aims to enroll a total of 100 individuals with these specific criteria."

Answered by AI

Is the age bracket of individuals being considered for this research limited to those below 45 years old?

"To be eligible for participation in this trial, patients must be between the ages of 10 and 17. There are a total of 21 studies available for individuals under the age of 18, as well as an additional 17 studies specifically designed for participants over the age of 65."

Answered by AI

Are there any available openings for patients to participate in this study?

"It appears that the information on clinicaltrials.gov indicates that this particular trial is not currently accepting new participants. The trial was first posted on January 15, 2024 and was last updated on December 21, 2023. However, it's worth noting that there are currently 32 other active studies actively seeking candidates for participation."

Answered by AI

Who else is applying?

What site did they apply to?
University of California
What portion of applicants met pre-screening criteria?
Did not meet criteria

Why did patients apply to this trial?

My 10yo son has TS. I was applying for him but the website didn’t allow for that so I am trying again.
PatientReceived 1 prior treatment
~67 spots leftby Feb 2029